Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - A nationwide population-based matched-control study in Taiwan

Table 2 Univariate HRs for lymphoid malignancy and all malignancies (excluding lymphoid malignancy) among patients and controls

	Total	Patients with herpes zoster	Matched-control subjects
Presence of lymphoid malignancy
Yes, no. (%) of patients	154 (0.07)	48 (0.11)	106 (0.06)
No, no. (%) of patients	212,105 (99.93)	42,348 (99.89)	169,757 (99.94)
Univariate HR^a (95% CI)	-	1.82 (1.29-2.55)	Reference
P value		0.0006
Presence of cancer (excluded lymphoid malignancy)
Yes, no. (%) of patients	4,865 (2.29)	1,027 (2.42)	3,838 (2.26)
No, no. (%) of patients	207,590 (97.71)	41,458 (97.58)	166,132 (97.74)
Univariate HR^a (95% CI)	-	1.07 (1.01-1.15)	Reference
P value		0.0465

ISSN: 1471-2407